Effect of 5-fluorocytosine and amphotericin B on Candida albicans infection in mice.
暂无分享,去创建一个
[1] A. R. English,et al. Pirbenicillin: Pharmacokinetic Parameters in Mice , 1976, Antimicrobial Agents and Chemotherapy.
[2] E. Grunberg,et al. Chemotherapeutic Activity of 5-Fluorocytosine and Amphotericin B Against Candida albicans in Mice , 1973, Antimicrobial Agents and Chemotherapy.
[3] E. Block,et al. The Combined Effect of 5-Fluorocytosine and Amphotericin B in the Therapy of Murine Cryptococcosis , 1973, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[4] J. Klastersky,et al. Clinical Significance of In Vitro Synergism Between Antibiotics in Gram-Negative Infections , 1972, Antimicrobial Agents and Chemotherapy.
[5] G. Medoff,et al. Synergistic Action of Amphotericin B and 5-Fluorocytosine Against Yeast-Like Organisms 1 , 1971, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[6] R. Perkins,et al. 5-fluorocytosine in the treatment of cryptococcal and candida mycoses. , 1971, Annals of internal medicine.
[7] S. Shadomy. Further In Vitro Studies with 5-Fluorocytosine , 1970, Infection and immunity.
[8] J. A. Mccay,et al. In vitro susceptibility of Cryptococcus neoformans to amphotericin B, hamycin, and 5-fluorocytosine. , 1968, Antimicrobial agents and chemotherapy.
[9] L. Friedman,et al. PATHOGENICITY OF CANDIDA , 1961, Journal of bacteriology.